RxDoctor Payments Data

Craig Vickstrom, MD

Family Medicine · Hibbing, MNNPI 1265541486

Payments from drug & device makers

$585in general payments, 2019–2025

Across 57 payments — averaging $10.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$402
  • GSK$65
  • AbbVie$25
  • Johnson & Johnson$23
  • Novartis$16
  • AMAG Pharmaceuticals, Inc.$14
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$57198%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$585 in reported general payments places this provider in the 90th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$9,807
Medicare patients
53
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready PenSecukinumab11$153,217
EliquisApixaban193$133,116
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$80,902
JanuviaSitagliptin Phosphate78$80,082
XareltoRivaroxaban51$77,371
TrulicityDulaglutide24$40,674
JardianceEmpagliflozin23$34,719
Invega SustennaPaliperidone Palmitate13$27,680
Combivent RespimatIpratropium/Albuterol Sulfate19$25,733
Breo ElliptaFluticasone/Vilanterol37$23,669
Victoza 3-PakLiraglutide17$22,523
MyrbetriqMirabegron35$13,877
OzempicSemaglutide11$11,217
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$10,531
NeuproRotigotine12$10,476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$65$108,143121 claims
Johnson & JohnsonXarelto, Invega Sustenna$23$105,05064 claims
MerckJanuvia$14$80,08278 claims
Lilly USA, LLCTrulicity$13$40,67424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in Hibbing

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →